Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 16Lymphoid 15Myeloid 10Gastrointestinal 5Classical hematology 5Plasma cell 4Dermatologic 4Sarcoma 3Genitourinary 2Thoracic 1Other solid neoplasm 1Other neoplasm 1NET 1Gynecologic 1Endocrine 1CNS 1

Conditions

Turcot syndrome 1Stomach Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Squamous Cell 1Microsatellite Instability 1Mesothelioma 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

lutetium Lu 177 dotatate 5Specimen Handling 4Magnetic Resonance Spectroscopy 4cabozantinib 3olaparib 2fludarabine 2X-Rays 2Phantoms, Imaging 2Cyclophosphamide 2tivozanib 1repotrectinib 1pembrolizumab 1pazopanib 1fludarabine phosphate 1entrectinib 1belinostat 1atezolizumab 1aldesleukin 1Yttrium-90 1Temozolomide 1Sunitinib 1Salts 1Octreotide 1Nivolumab 1Lutetium-177 1Lutetium 1Introns 1Interferon alpha-2 1Immunoglobulin G 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
fludarabine phosphate × NET × 30 days × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡